{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/amenorrhoea/diagnosis/assessment-for-cause-secondary-amenorrhoea/","result":{"pageContext":{"chapter":{"id":"837053aa-eb61-5825-9d01-6f1803d01484","slug":"assessment-for-cause-secondary-amenorrhoea","fullItemName":"Assessment for cause - secondary amenorrhoea","depth":2,"htmlHeader":"<!-- begin field df3d1ac0-14d9-400b-9d69-a9a4009540b0 --><h2>How should I assess for an underlying cause of secondary amenorrhoea?</h2><!-- end field df3d1ac0-14d9-400b-9d69-a9a4009540b0 -->","summary":"","htmlStringContent":"<!-- begin item 80524d0b-7e41-4543-835b-a9a400953ff5 --><!-- begin field 96dca808-b30e-4077-ad3b-a9a4009540b0 --><p><strong>To assess for a <a class=\"topic-reference internal-reference\" href=\"/topics/amenorrhoea/background-information/causes/#causes-of-secondary-amenorrhoea\">cause</a> of secondary amenorrhoea:</strong></p><ul><li><strong>Take a history.</strong> <ul><li>Exclude physiological causes, including pregnancy, lactation, and menopause (in women 40 years of age or older).</li><li>Ask about:<ul><li>Contraceptive use (extended-cycle combined oral contraceptives, injectable progesterone, implantable etonogestrel [Nexplanon®], and levonorgestrel intrauterine system [Mirena®] may cause amenorrhea).</li><li>Hot flushes and vaginal dryness (suggesting premature ovarian insufficiency [POI] or natural menopause).</li><li>Headaches, visual disturbances, or galactorrhoea (suggesting a pituitary tumour).</li><li>Acne, hirsutism, and weight gain (suggesting polycystic ovary syndrome [PCOS]).</li><li>Stress, depression, weight loss, disturbance of perception of weight or shape, level of exercise, and chronic systemic illness (suggesting hypothalamic dysfunction).</li><li>Symptoms of thyroid and other endocrine disease.</li><li>A history of obstetric or surgical procedures (such as endometrial curettage) that may have resulted in intrauterine adhesions.</li><li>A history of chemotherapy and pelvic radiotherapy (which can cause POI); and cranial radiotherapy, head injury, or major obstetric haemorrhage (which can cause hypopituitarism).</li><li>Drugs (such as antipsychotics, which can cause increased prolactin levels) and illicit drug use (in particular cocaine and opiates, which can cause hypogonadism).</li><li>A family history of cessation of menses before 40 years of age (suggesting POI).</li></ul></li></ul></li><li><strong>Examine the woman.</strong><ul><li>Measure height and body weight, and calculate body mass index (BMI) for weight-related causes of amenorrhoea (a high BMI may suggest PCOS; a low BMI may suggest an eating disorder or the <a class=\"topic-reference internal-reference\" href=\"/topics/amenorrhoea/background-information/causes/#causes-of-secondary-amenorrhoea\">female athlete triad</a>).</li><li>Examine for features of:<ul><li>Cushing's syndrome (striae, buffalo hump, significant central obesity, easy bruising, hypertension, and proximal muscle weakness).</li><li>Thyroid disease. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/hyperthyroidism/\">Hyperthyroidism</a> and <a class=\"topic-reference external-reference\" href=\"/topics/hypothyroidism/\">Hypothyroidism</a> for more information. </li><li>Excess androgens (hirsutism, acne) or virilization (hirsutism, acne, deep voice, temporal balding, increase in muscle bulk, breast atrophy, and clitoromegaly).</li><li>Decreased endogenous estrogen (reddened or thin vaginal mucosa).</li></ul></li><li>If appropriate, examine for galactorrhoea (suggesting raised prolactin levels).</li><li>Assess visual fields (if a pituitary tumour is suspected).</li></ul></li><li><strong>Consider carrying out the following preliminary investigations in primary care to aid diagnosis and/or guide referral (see also <a class=\"topic-reference internal-reference\" href=\"/topics/amenorrhoea/diagnosis/assessment-for-cause-secondary-amenorrhoea/#interpretation-of-investigation-findings\">Interpretation of investigation findings</a>):</strong><ul><li>Follicle-stimulating hormone and luteinizing hormone.</li><li>Prolactin level. <ul><li>Do not examine the breasts before taking blood for prolactin levels, as this may then be falsely elevated. If the breasts have been examined, delay the blood test for at least 48 hours.</li></ul></li><li>Total testosterone.</li><li>Thyroid-stimulating hormone.</li><li>Ultrasound scan (if PCOS is suspected).</li><li>Other investigations as suggested by clinical findings.</li></ul></li></ul><!-- end field 96dca808-b30e-4077-ad3b-a9a4009540b0 --><!-- end item 80524d0b-7e41-4543-835b-a9a400953ff5 -->","topic":{"id":"635ca828-9f27-5c84-b276-9a303cb30217","topicId":"968f93cb-fee3-4df5-83c2-a670cea5f458","topicName":"Amenorrhoea","slug":"amenorrhoea","lastRevised":"Last revised in August 2020","chapters":[{"id":"3084e6c6-7940-5e97-9fd1-ecb1526af0ec","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"05c35b63-85f8-528e-b16f-a5346f53c7af","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"ccc80bf0-145e-5a0b-a37c-5a33f15f2e2e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"6fdd6e3b-ed5e-5308-be10-14a6f09632b8","slug":"changes","fullItemName":"Changes"},{"id":"6c074480-101b-502d-b5a5-645e8620302d","slug":"update","fullItemName":"Update"}]},{"id":"3f4f9618-bd40-5219-8485-6bba1538b0d0","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"6cebc623-7ec5-59d8-a838-972a8119c50e","slug":"goals","fullItemName":"Goals"},{"id":"f92a2577-5a88-5e7a-ab16-bf87344977a2","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"934ecd3e-77fb-5e9b-9698-5b74862da801","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"78664cf2-21cd-5b31-8d73-e7dc692120ea","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"749d6d4c-eb45-56e9-9b4d-62cc5798b9e0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"9f7c349f-2f97-5b8a-b073-b638b6f43c0b","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"9ca190f3-629d-57ca-8291-a3ea5b6121f9","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"04b120b8-de8f-59b5-a1bb-8104f57db04a","slug":"definition","fullItemName":"Definition"},{"id":"5d9e7439-6e78-51d2-a454-3a15abc5b4bb","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a96e50cf-494b-5f87-8a34-be56f2aff82e","slug":"causes","fullItemName":"Causes"},{"id":"923165de-ebc1-558d-bb85-61d331eccf9a","slug":"complications","fullItemName":"Complications"}]},{"id":"605ec635-9408-5c63-80f1-27cc6fb4abe3","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6e7a254f-f04a-5175-86cb-7edd443f7d08","slug":"when-to-suspect-primary-amenorrhoea","fullItemName":"When to suspect primary amenorrhoea"},{"id":"1acb9357-e5d7-5c08-9e96-f7969bbd443c","slug":"assessment-for-cause-primary-amenorrhoea","fullItemName":"Assessment for cause - primary amenorrhoea"},{"id":"14126b3e-6c95-50fe-bfe0-b6fa96c83f62","slug":"when-to-suspect-secondary-amenorrhoea","fullItemName":"When to suspect secondary amenorrhoea"},{"id":"837053aa-eb61-5825-9d01-6f1803d01484","slug":"assessment-for-cause-secondary-amenorrhoea","fullItemName":"Assessment for cause - secondary amenorrhoea"}]},{"id":"3588d9eb-4131-594c-819d-39bd1ff21ca3","fullItemName":"Management","slug":"management","subChapters":[{"id":"bbc8ee17-2dd5-5faf-af1a-c0d72235b826","slug":"primary-amenorrhoea","fullItemName":"Scenario: Primary amenorrhoea"},{"id":"06391fac-7a04-5862-9279-2fea0c0708d9","slug":"secondary-amenorrhoea","fullItemName":"Scenario: Secondary amenorrhoea"}]},{"id":"d2cba32a-a527-597d-901a-2337f2bd3492","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"516d0c94-b12d-53cd-b7b4-837a8b98697c","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"1a337663-3dd2-54df-b78d-676b1c9818ef","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"20d0143f-fdcf-5847-8aee-bf3d3a60b424","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"960991f6-3dae-54d7-bf3f-cb49e9e1adc8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"45c9aa84-4b27-5a45-b280-415849c9af1d","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"2b117ca7-80c9-5ea2-b944-63dce78bd1ad","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"bd8c3717-761d-5601-aad0-481c09055389","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"605ec635-9408-5c63-80f1-27cc6fb4abe3","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"f184c87f-7ab9-5e08-9535-805ff24351c1","slug":"interpretation-of-investigation-findings","fullItemName":"Interpretation of investigation findings","depth":3,"htmlHeader":"<!-- begin field 7e1196a6-3608-442d-b403-a9a4009577ff --><h3>Interpretation of investigation findings</h3><!-- end field 7e1196a6-3608-442d-b403-a9a4009577ff -->","summary":null,"htmlStringContent":"<!-- begin item 47077806-283c-492f-b97d-a9a4009577d1 --><!-- begin field 0bed3ed9-9989-4f37-9aab-a9a4009577ff --><p><strong>See Table 1 for laboratory findings in common causes of secondary amenorrhoea. </strong></p><ul><li><strong>Follicle-stimulating hormone (FSH) and luteinizing hormone (LH)</strong><ul><li>High FSH and LH levels on two occasions suggest premature ovarian insufficiency (in women younger than 40 years of age).</li><li>Normal or low FSH levels and normal or low LH levels suggest hypothalamic causes (weight loss, excessive exercise, stress, or rarely, a hypothalamic or pituitary tumour).</li><li>Normal FSH levels and normal or moderately increased LH levels may be found in polycystic ovary syndrome (PCOS).</li></ul></li><li><strong>Prolactin levels</strong><ul><li>Prolactin levels greater than 1000 mIU/L usually warrant further investigation by an endocrinologist (usually magnetic resonance imaging [MRI] of the pituitary fossa is required). Causes include pituitary adenoma, empty sella syndrome, hypothyroidism, and drugs (including antipsychotics [particularly risperidone], antidepressants [particularly selective serotonin reuptake inhibitors], and antiemetics [such as metoclopramide or domperidone]).</li><li>If prolactin levels are mildly elevated (for example 500–1000 mIU/L, normal range less than 500 mIU/L), it should be repeated before referral.</li><li>The most likely causes of mild hyperprolactinaemia in primary care are stress and drugs (such as antipsychotics).</li><li>Other causes include:<ul><li>Pregnancy and breastfeeding.</li><li>Recent breast examination (if the breasts have been examined, the blood test should be delayed for at least 48 hours).</li><li>Needle phobia or traumatic venesection (can double or occasionally quadruple basal prolactin concentrations).</li><li>PCOS (in 10–20% of people; rarely above 1000 mIU/L).</li><li>Renal impairment (occasionally associated with mild hyperprolactinaemia; typically less than 2000 mIU/L).</li><li>Hypothyroidism (uncommon, often still within the reference range and only rarely above 1200 mIU/L). </li></ul></li><li>Persistent moderate elevations may be due to pituitary adenomas.</li></ul></li><li><strong>Thyroid-stimulating hormone</strong><ul><li>See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/hypothyroidism/\">Hypothyroidism</a> and <a class=\"topic-reference external-reference\" href=\"/topics/hyperthyroidism/\">Hyperthyroidism</a> for more information.</li></ul></li><li><strong>Total testosterone</strong><ul><li>High levels of total testosterone (5.0 nanomol/L or greater) warrant investigation to exclude other causes, such as Cushing's syndrome, late-onset congenital adrenal hyperplasia, or an androgen-secreting tumour.</li><li>A moderately increased testosterone level (2.5–5.0 nanomol/L) may be seen in PCOS.</li></ul></li><li><strong>Ultrasound scan</strong><ul><li>Polycystic ovaries on ultrasound are defined as the presence of 12 or more follicles (measuring 2–9 mm in diameter) in one or both ovaries and/or increased ovarian volume (greater than 10 cm<sup>3</sup>).</li></ul></li></ul><p><strong>Table 1. </strong>Laboratory findings in common causes of secondary amenorrhoea.</p><table><thead><tr><th>State</th><th>FSH</th><th>LH</th><th>Prolactin</th><th>Testosterone</th></tr></thead><tbody><tr><td><strong>Hyperprolactinaemia</strong></td><td>Normal/low</td><td>Normal/low</td><td>High</td><td>Normal</td></tr><tr><td><strong>Polycystic ovary syndrome</strong></td><td>Normal</td><td>Normal/slightly increased in 40%</td><td>Normal/slightly increased in 5–30%</td><td><p>Normal/moderately increased</p><p>Free androgen index increased</p></td></tr><tr><td><strong>Ovarian failure</strong></td><td>High</td><td>High</td><td>Normal</td><td>Normal</td></tr><tr><td><strong>Hypothalamic (for example weight loss, excessive exercise, or stress)</strong></td><td>Low/normal</td><td>Low/normal</td><td>Normal</td><td>Normal</td></tr><tr><td colspan=\"5\"><p>FSH = follicle-stimulating hormone</p><p>LH = luteinizing hormone</p></td></tr><tr><td colspan=\"5\"><strong>Data from: </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Rees, 2003</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Warren and Hagey, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Practice Committee of the American Society for Reproductive Medicine, 2008</a>]</td></tr></tbody></table><!-- end field 0bed3ed9-9989-4f37-9aab-a9a4009577ff --><!-- end item 47077806-283c-492f-b97d-a9a4009577d1 -->","subChapters":[]},{"id":"78d2b85f-c5ec-5b64-ac73-d109278461f9","slug":"basis-for-recommendation-4c0","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field f3b6e116-b58d-4746-bdeb-a9a40153bbd3 --><h3>Basis for recommendation</h3><!-- end field f3b6e116-b58d-4746-bdeb-a9a40153bbd3 -->","summary":null,"htmlStringContent":"<!-- begin item 4c0be5e0-d9e0-43d1-a54b-a9a40153bb53 --><!-- begin field e6398cf1-3ffd-4c9a-aa4f-a9a40153bbd3 --><h4>History and examination</h4><ul><li>These recommendations are based largely on expert opinion in the European Society of Human Reproduction and Embyrology (ESHRE) guideline on <em>Management of women with premature ovarian insufficiency</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">ESHRE, 2015</a>], review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Ledger and Skull, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Warren and Hagey, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Wilson et al, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Dickerson et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Heiman, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Klein, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">BMJ, 2018b</a>], and gynaecology textbooks [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Balen, 2000</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Rees, 2003</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Balen, 2004</a>].</li><li>Excluding pregnancy is widely recommended; in particular, one expert notes that 'it is common to see one or two patients a year who are pregnant despite denying the possibility' [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Balen, 2000</a>].</li></ul><h4>Investigations</h4><ul><li>There is no consensus in the published literature on the most appropriate first-line investigations for secondary amenorrhoea. The recommended investigations are based on reports of the relative frequencies of underlying causes of secondary amenorrhoea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Balen, 2000</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Balen, 2004</a>], recommendations from the American Society for Reproductive Medicine [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Practice Committee of the American Society for Reproductive Medicine, 2008</a>] and the Endocrine Society [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Gordon, 2017</a>], and expert opinion in review articles on amenorrhoea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Ledger and Skull, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Wilson et al, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Dickerson et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Heiman, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">BMJ, 2018b</a>] and a gynaecology textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Balen, 2000</a>].<ul><li>Expert opinion in a review article is that initial investigations should be performed in primary care before the woman is seen in secondary care [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Ledger and Skull, 2004</a>]. They state that although amenorrhoea has traditionally been investigated using a step-wise approach, this is likely to lead to an increased number of visits to complete each stage of investigation, and thus increase expense.</li><li>PCOS, premature ovarian failure, hyperprolactinaemia, and hypothalamic dysfunction (due to, for example, weight loss, stress, or excessive exercise) are the most common causes of secondary amenorrhoea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Balen, 2000</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Balen, 2004</a>]. Total testosterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and prolactin measurements are appropriate first-line tests for these conditions.</li><li>Thyroid disease appears to be a relatively rare cause of secondary amenorrhoea and some experts recommend TSH measurement only if the woman has features of thyroid disease.</li><li>The Royal College of Obstetricians and Gynaecologists (RCOG) recommends measurement of total testosterone for the investigation of polycystic ovary syndrome (PCOS) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">RCOG, 2014</a>], which is a common cause of secondary amenorrhoea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Balen, 2000</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Balen, 2004</a>]. Routine measurement of total testosterone is also recommended because there is some evidence that women conceal hirsutism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Balen et al, 2005</a>].</li></ul></li></ul><h4>Interpretation of investigation findings</h4><ul><li><strong>Follicle-stimulating hormone (FSH) and luteinizing hormone (LH)</strong><ul><li>The information on interpreting FSH and LH levels is based on a Canadian guideline on endocrine testing in amenorrhoea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Alberta Medical Association, 2008b</a>] and on expert opinion in a gynaecology textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Balen, 2000</a>].</li></ul></li><li><strong>Prolactin levels</strong><ul><li>The information on interpreting prolactin levels is based on expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Hayden and Balen, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Practice Committee of the American Society for Reproductive Medicine, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Heiman, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Klein, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Levy, 2014</a>].<ul><li>Elevated prolactin levels, whatever the cause, inhibit the secretion and effect of gonadotropins, and warrant magnetic resonance imaging (MRI) of the pituitary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Klein, 2013</a>].</li><li>In primary care, stress and drug effects are the most likely causes of transient hyperprolactinaemia. A single measurement of prolactin concentration is usually sufficient to exclude hyperprolactinaemia. Nevertheless, needle phobia or traumatic venesection can double or occasionally quadruple basal prolactin concentrations, and a repeat test under different circumstances can provide reassurance [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Levy, 2014</a>].</li></ul></li></ul></li><li><strong>Total testosterone levels</strong><ul><li>The information on interpreting total testosterone levels is based on the RCOG guideline <em>Long-term consequences of polycystic ovary syndrome </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">RCOG, 2014</a>] and an expert opinion in a gynaecology textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Balen, 2012</a>].</li></ul></li><li><strong>Ultrasound scan</strong><ul><li>The diagnostic appearance of polycystic ovaries on ultrasound are based on the widely accepted Rotterdam diagnostic criteria [<a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/amenorrhoea/references/\">Ehrmann, 2005</a>].</li></ul></li></ul><!-- end field e6398cf1-3ffd-4c9a-aa4f-a9a40153bbd3 --><!-- end item 4c0be5e0-d9e0-43d1-a54b-a9a40153bb53 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}